ROBINS HARLAN S
SEC CIK 1780851 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | CSO | 1.30M | — | $33.06M | 34 | 2021-07-19 | 2026-07-21 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-23 19:34 | 2026-07-21 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.55 | +284.8K | 1.30M | +28% | +$1.87M |
| DMT | 2026-07-23 19:34 | 2026-07-21 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $21.89 | -492.4K | 812.1K | -38% | -$10.78M |
| MT | 2026-07-07 18:52 | 2026-07-02 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $22.01 | -386.2K | 1.02M | -27% | -$8.50M |
| MT | 2026-06-17 20:11 | 2026-06-15+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $17.41 | -106.2K | 1.41M | -7% | -$1.85M |
| T | 2026-04-10 18:48 | 2026-04-08 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $14.85 | -10.0K | 1.51M | -0.7% | -$148.5K |
| M | 2026-03-13 | 2026-03-11 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $13.17 | -470.3K | 1.85M | -20% | -$6.19M |
| M | 2026-03-06 | 2026-03-04+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +837.0K | 1.28M | +188% | $0 |
| M | 2026-03-04 | 2026-03-02+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $16.19 | -24.2K | 1.17M | -2% | -$392.3K |
| M | 2026-02-04 | 2026-02-02+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $18.68 | -42.8K | 1.19M | -3% | -$799.1K |
| 2026-01-08 | 2026-01-06 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $16.44 | -10.0K | 1.22M | -0.8% | -$164.4K | |
| M | 2025-12-05 | 2025-12-03+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $18.07 | -37.2K | 1.23M | -3% | -$672.5K |
| 2025-11-12 | 2025-11-10 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $14.82 | -10.0K | 1.27M | -0.8% | -$148.2K | |
| D | 2025-05-05 | 2025-05-01 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $7.35 | -68.4K | 1.28M | -5% | -$502.8K |
| D | 2025-05-05 | 2025-05-01 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +68.4K | 1.35M | +5% | +$432.4K |
| D | 2025-03-26 | 2025-03-24 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $9.00 | -1,698 | 1.28M | -0.1% | -$15.3K |
| D | 2025-03-26 | 2025-03-24 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +1,698 | 1.28M | +0.1% | +$10.7K |
| 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +355.0K | 1.38M | +35% | $0 | |
| M | 2025-03-06 | 2025-03-05 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $6.99 | -96.7K | 1.34M | -7% | -$675.2K |
| 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +354.6K | 1.02M | +53% | $0 | |
| 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +354.6K | 666.6K | +114% | $0 | |
| D | 2022-03-08 | 2022-03-04 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +247.1K | 316.5K | +356% | $0 |
| D | 2022-03-08 | 2022-03-07 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale | $12.01 | -4,517 | 312.0K | -1% | -$54.2K |
| DM | 2021-11-19 | 2021-11-17+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $32.00 | -4,000 | 69.4K | -5% | -$128.0K |
| DM | 2021-11-19 | 2021-11-17+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.55 | +4,000 | 69.7K | +6% | +$26.2K |
| DM | 2021-10-21 | 2021-10-19+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $33.71 | -11.2K | 69.4K | -14% | -$377.6K |
| DM | 2021-10-21 | 2021-10-19+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.55 | +11.2K | 73.1K | +18% | +$73.4K |
| DM | 2021-10-08 | 2021-10-06+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $32.95 | -11.7K | 73.1K | -14% | -$385.0K |
| DM | 2021-10-08 | 2021-10-06+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| DM | 2021-09-15 | 2021-09-13+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| DM | 2021-09-15 | 2021-09-13+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $36.98 | -11.7K | 69.4K | -14% | -$432.1K |
| DM | 2021-08-27 | 2021-08-25+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $34.25 | -11.7K | 69.4K | -14% | -$400.2K |
| DM | 2021-08-27 | 2021-08-25+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| DM | 2021-07-21 | 2021-07-19+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| DM | 2021-07-21 | 2021-07-19+ | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | CSO | S - Sale+OE | $37.47 | -11.7K | 72.0K | -14% | -$437.9K |
Purchase Sale Sale after option exercise All abbreviations